Cabot (NYSE:CBT) Cut to “Hold” at Mizuho

Mizuho lowered shares of Cabot (NYSE:CBTFree Report) from a strong-buy rating to a hold rating in a research report report published on Wednesday morning,Zacks.com reports.

Several other brokerages also recently commented on CBT. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. JPMorgan Chase & Co. dropped their price target on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research report on Friday, November 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. UBS Group increased their target price on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price target on shares of Cabot in a research note on Wednesday. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $73.75.

View Our Latest Stock Report on Cabot

Cabot Stock Down 2.0%

Cabot stock opened at $74.69 on Wednesday. The firm has a market capitalization of $3.90 billion, a price-to-earnings ratio of 13.08, a PEG ratio of 3.99 and a beta of 0.88. The company’s 50 day simple moving average is $69.28 and its 200 day simple moving average is $71.69. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.08. Cabot has a fifty-two week low of $58.33 and a fifty-two week high of $89.15.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.13. The company had revenue of $849.00 million for the quarter, compared to analyst estimates of $889.11 million. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The business’s revenue for the quarter was down 11.1% compared to the same quarter last year. During the same period last year, the business posted $1.76 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, sell-side analysts anticipate that Cabot will post 7.57 EPS for the current year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Friday, February 27th will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Friday, February 27th. Cabot’s dividend payout ratio (DPR) is currently 31.52%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Legato Capital Management LLC bought a new position in Cabot in the fourth quarter valued at $672,000. Global Retirement Partners LLC grew its holdings in shares of Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 466 shares in the last quarter. Covestor Ltd grew its holdings in shares of Cabot by 63.1% in the 4th quarter. Covestor Ltd now owns 2,208 shares of the specialty chemicals company’s stock valued at $146,000 after acquiring an additional 854 shares in the last quarter. ProShare Advisors LLC increased its position in shares of Cabot by 13.8% in the fourth quarter. ProShare Advisors LLC now owns 16,460 shares of the specialty chemicals company’s stock valued at $1,091,000 after acquiring an additional 1,997 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in Cabot by 56,330.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 107,218 shares of the specialty chemicals company’s stock worth $7,106,000 after acquiring an additional 107,028 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

See Also

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.